Bajaj Healthcare Share Price

Overview
Recos
News
Analysis
Financials
Forecast
Technicals
Peers
Shareholdings
MF
F&O
Corp Actions
About

Bajaj Healthcare Share Price

299.20-3.11 (-1.03%)

Closed
As On: 17 Jun, 2026, 03:56 PM IST
As On: 17 Jun, 2026, 03:57 PM IST

Sector: Pharmaceuticals
Industry: Pharma - Indian

1D
1W
1M
3M
6M
1Y
5Y

Loading...

Try ETMarkets GPTNEW

Open	303.95
High	305.00
Low	298.00
Prev Close	302.30
Volume	1,14,640
VWAP(₹)	301.17

Key Metrics

PE Ratio(x)	63.88
EPS - TTM(₹)	4.68
MCap(₹ Cr.)	1,007.19
MCap Rank	88
PB Ratio(x)	1.91
Div Yield(%)	0.50
Face Value(₹)	5.00
52W High(₹)	552.60
52W Low(₹)	272.35
MCap/Sales	1.60
Beta(1 Month)	-
BV/Share(₹)	158.34

Bajaj Healthcare share price insights

PAT: Slipping to Red
Company has posted a loss of Rs 22.85 cr in Mar 31, 2026 quarter after 3 consecutive quarter of profits. (Source: Standalone Financials)
Employee & Interest Expense
Company has spent 3.64% of its operating revenues towards interest expenses and 10.27% towards employee cost in the year ending Mar 31, 2026. (Source: Standalone Financials)
Bajaj Healthcare Share Price Update
Bajaj Healthcare Ltd. share price moved down by -1.03% from its previous close of Rs 302.30. Bajaj Healthcare Ltd. stock last traded price is 299.20
Share Price Value
Today/Current/Last 299.20298.70
Previous Day 302.30302.60

Found Insights useful?

Bajaj Healthcare Share Price Returns

1 Day	-1.03%
1 Month	5.3%
3 Months	7.55%
1 Year	-43.85%
3 Years	-6.35%
5 Years	N.A.

Bajaj Healthcare Share Recommendations

No Recommendations details available for this stock.
Check out other stock recos.

News & Analysis

View all Bajaj Healthcare Share News & Announcements

Share Analysis

EARNINGS

FUNDAMENTAL

RELATIVE VALUATION

RISK

PRICE MOMENTUM

Unlock Stock Score, Analyst' Ratings & Recommendations

Score on 10-point scale
Ratings by analysts
Stock performance

JOIN ET PRIME

Financials

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
Total Income	156.01	162.87	149.57	149.71	168.04
Total Income Growth (%)	-4.21	8.89	-0.10	-10.91	34.26
Total Expenses	171.26	137.74	128.05	129.96	150.25
Total Expenses Growth (%)	24.33	7.57	-1.47	-13.50	39.11
EBIT	-15.24	25.13	21.52	19.75	17.80
EBIT Growth (%)	-160.66	16.76	8.96	10.97	3.71
Profit after Tax (PAT)	-22.85	15.67	11.11	11.83	11.18
PAT Growth (%)	-245.79	41.09	-6.12	5.87	-4.64
EBIT Margin (%)	-9.77	15.43	14.39	13.19	10.59
Net Profit Margin (%)	-14.65	9.62	7.43	7.90	6.65
Basic EPS (₹)	-7.16	4.96	3.53	3.74	3.54

	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Total Revenue	618.17	562.01	482.10	674.89	681.33
Total Revenue Growth (%)	9.99	16.57	-28.57	-0.95	2.63
Total Expenses	556.00	516.00	454.45	616.67	591.65
Total Expenses Growth (%)	7.75	13.54	-26.31	4.23	8.54
Profit after Tax (PAT)	15.77	39.50	-83.79	43.02	71.39
PAT Growth (%)	-60.08	-	-294.76	-39.73	-14.11
Operating Profit Margin (%)	13.81	13.62	12.11	12.04	15.04
Net Profit Margin (%)	2.58	7.27	-17.69	6.39	10.49
Basic EPS (₹)	4.98	13.29	-30.36	15.59	25.87

All figures in Rs Cr, unless mentioned otherwise

Insights

PAT: Slipping to Red
Company has posted a loss of Rs 22.85 cr in Mar 31, 2026 quarter after 3 consecutive quarter of profits. (Source: Standalone Financials)
Employee & Interest Expense
Company has spent 3.64% of its operating revenues towards interest expenses and 10.27% towards employee cost in the year ending Mar 31, 2026. (Source: Standalone Financials)

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Total Assets	923.22	833.05	765.13	901.46	721.10
Total Assets Growth (%)	10.82	8.88	-15.12	25.01	37.19
Total Liabilities	390.21	366.88	486.77	533.77	392.62
Total Liabilities Growth (%)	6.36	-24.63	-8.81	35.95	46.93
Total Equity	533.00	466.16	278.36	367.69	328.49
Total Equity Growth (%)	14.34	67.47	-24.29	11.93	27.12
Current Ratio (x)	1.92	1.89	1.09	1.17	1.24
Total Debt to Equity (x)	0.44	0.48	1.19	1.13	0.78
Contingent Liabilities	0.00	34.51	13.65	15.97	15.12

All figures in Rs Cr, unless mentioned otherwise

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Net Cash flow from Operating Activities	58.08	21.62	92.29	-22.32	0.69
Net Cash used in Investing Activities	-47.78	-14.82	-11.24	-93.43	-74.80
Net Cash flow from Financing Activities	24.33	-6.38	-96.60	131.50	61.85
Net Cash Flow	34.63	0.43	-15.55	15.75	-12.27
Closing Cash & Cash Equivalent	37.24	2.60	2.17	17.72	1.97
Closing Cash & Cash Equivalent Growth (%)	1,330.04	19.73	-87.73	797.28	-86.13
Total Debt/ CFO (x)	4.02	10.30	3.60	-18.56	374.25

All figures in Rs Cr, unless mentioned otherwise

Insights

Increase in Cash from Investing
Company has used Rs 47.78 cr for investing activities which is an YoY increase of 222.51%. (Source: Standalone Financials)

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Return on Equity (%)	2.95	8.47	-30.10	11.70	21.73
Return on Capital Employed (%)	14.28	13.78	17.71	17.42	25.63
Return on Assets (%)	1.70	4.74	-10.95	4.77	9.89
Interest Coverage Ratio (x)	5.04	3.65	2.86	4.74	9.50
Asset Turnover Ratio (x)	0.70	0.68	0.57	0.83	1.09
Price to Earnings (x)	62.11	53.76	-9.63	19.57	13.18
Price to Book (x)	1.83	4.55	2.90	2.29	2.86
EV/EBITDA (x)	10.46	22.98	13.38	11.41	9.96
EBITDA Margin (%)	18.32	18.76	17.94	16.10	17.64

Found Financials useful?

Technicals

Buy/Sell Signals
No Data Available
Price Analysis
No Data Available
Pivot Levels
R1 - Pivot
-
S1 -
R2 - S2 -
R3 - S3 -
Average True Range
5 Days 14 Days 28 Days
- - -

Peer Comparison

Ratio Performance

NAME	P/E (x)	P/B (x)	ROE %	ROCE %	ROA %	Rev CAGR [3Yr]	OPM	NPM	Basic EPS	Current Ratio	Total Debt/ Equity (x)	Total Debt/ CFO (x)
Bajaj Healthcare	63.88	1.89	2.95	14.28	1.70	-2.86	13.81	2.58	4.98	1.92	0.44	4.02
Ind-Swift Labs	34.07	1.02	2.99	4.33	2.47	-17.67	9.58	6.44	4.95	3.83	0.01	-0.28
Jagsonpal Pharm	31.82	4.96	15.59	21.02	13.60	7.19	21.10	14.99	6.40	5.06	0.00	0.00
Syncom Form	17.49	3.22	18.41	23.76	14.31	29.31	20.90	15.62	0.81	3.18	0.00	0.03
Lincoln Pharma	14.35	1.66	11.60	14.96	9.87	9.66	17.38	13.09	43.88	5.25	0.01	0.04
Add More

Annual Ratios (%)

Choose from Peers

Fermenta Biotech
Themis Medicare
Wanbury Ltd
Kopran Ltd
Anuh Pharma

Choose from Stocks

Stock Performance

CHART
TABLE

1D
1W
1M
3M
6M
1Y
5Y

Choose from Peers
Choose from Stocks

Shareholding Pattern

Total Shareholdings
Category No. of Shares Percentage % Change QoQ
Promoters 1,96,22,885 58.29 % -0.89
Pledge 0 0.00 % 0.00
FII 6,65,859 1.98 % 0.80
DII 9,79,504 2.91 % -0.04
MF 5,69,477 1.69 % 0.03
Others 1,23,94,413 36.82 % 0.15
QoQ Change
Category Mar 2026 Dec 2025 Sep 2025 Jun 2025
Promoters 58.29 59.19 59.19 59.19
Pledge 0.00 0.00 0.00 0.00
FII 1.98 1.18 1.12 1.09
DII 2.91 2.96 2.99 3.16
Mutual Funds 1.69 1.66 1.66 1.66
Others 36.82 36.67 36.70 36.56

Mutual Funds Ownership

MF Ownership as on 31 May 2026

HDFC Pharma And Healthcare Direct-G
Equity: Sectoral-Pharma
- 17.19
  Amount Invested (in Cr.)
- 0.73%
  % of AUM
- 0.00
  % Change (MoM basis)
Motilal Oswal BSE Healthcare ETF-G
Equity: Sectoral-Pharma
- 0.01
  Amount Invested (in Cr.)
- 0.03%
  % of AUM
- -9.59
  % Change (MoM basis)
Bandhan BSE Healthcare Index Direct-G
Equity: Sectoral-Pharma
- 0.01
  Amount Invested (in Cr.)
- 0.03%
  % of AUM
- 6.59
  % Change (MoM basis)

View all Mutual Fund Schemes

Bajaj Healthcare Top Searches

Corporate Actions

Recent
Final
30%
May 08, 2026
Board Meeting
Audited Results & Final Dividend
May 04, 2026
Board Meeting
To consider Fund Raising
Mar 13, 2026

Announced on	Meeting on
May 04, 2026	May 08, 2026
Audited Results & Final Dividend
Mar 13, 2026	Mar 18, 2026
To consider Fund Raising
Jan 12, 2026	Jan 16, 2026
Quarterly Results
Oct 13, 2025	Oct 17, 2025
Quarterly Results
Jul 22, 2025	Jul 28, 2025
Quarterly Results

Dividends
Announced on Ex-Date Dividend%
May 26, 2025 Sep 19, 2025 20%
May 24, 2024 Sep 23, 2024 20%
May 30, 2023 Sep 22, 2023 20%
May 17, 2022 Sep 22, 2022 30%
May 08, 2026 - 30%
Bonus
Announced on Ex-Date
Feb 19, 2019 Apr 09, 2019
Bonus Ratio: 1 share(s) for every 1 shares held
Splits
Announced on Ex-Date
Aug 13, 2021 Sep 28, 2021
Split: Old FV10.0| New FV:5.0
Rights
No Data Available

AGM/EGM Meetings

Announced on	Meeting on
Jan 19, 2026	Feb 23, 2026
-
Sep 08, 2025	Sep 26, 2025
-
Sep 17, 2024	Sep 30, 2024
Rs.1.0000 per share(20%)Final Dividend & A.G.M.
Jul 16, 2024	Aug 07, 2024
-
Sep 08, 2023	Sep 30, 2023
Rs.1.0000 per share(20%)Final Dividend & A.G.M.

About Bajaj Healthcare

Bajaj Healthcare Ltd., incorporated in the year 1993, is a Small Cap company (having a market cap of Rs 1,007.19 Crore) operating in Pharmaceuticals sector.

Bajaj Healthcare Ltd. key Products/Revenue Segments include Pharmaceuticals, Sale of services for the year ending 31-Mar-2025.

For the quarter ended 31-03-2026, the company has reported a Standalone Total Income of Rs 156.01 Crore, down 4.21 % from last quarter Total Income of Rs 162.87 Crore and down 7.16 % from last year same quarter Total Income of Rs 168.04 Crore. Company has reported net profit after tax of Rs -22.85 Crore in latest quarter.

The company’s top management includes Mr.Sajankumar R Bajaj, Mr.Anil C Jain, Ms.Namrata S Bajaj, Mr.Pakshal A Jain, Mr.Hemant R Karnik, Mrs.Kejal N Shah, Mr.Ram B Banarase, Mr.Yaqoob Ali, Mr.Rohan Parekh, Ms.Monica Tanwar. Company has Chaturvedi & Agrawal as its auditors. As on 31-03-2026, the company has a total of 3.37 Crore shares outstanding.

Bajaj Healthcare Share Price Today is Rs. 299.20. On previous day, the Bajaj Healthcare Share Price (NSE) closed at Rs. 299.2, featuring among the most traded securities on the National Stock Exchange.

Shareholdings:
As of 31st Mar, 2026, the promoter held 58.29% of the stake in Bajaj Healthcare shares, out of which 0.0% was pledged. On the same date, foreign institutional investors' (FII) holdings of Bajaj Healthcare stocks was 1.98% as compared to 1.18% in Dec 2025 with increase of 0.8%. The domestic institutional investors (DII) holdings on 31st Mar, 2026 was 2.91% as compared to 2.96% in Dec 2025 with decrease of 0.05%. Out of the total DII holdings in Bajaj Healthcare shares 1.69% was held by mutual funds. The rest including public held is 36.82%. Bajaj Healthcare stock price is reflected on both the exchanges - BSE and NSE.

Dividend, Bonus & Split Information:
Bajaj Healthcare Dividend: Ever since 1993, Bajaj Healthcare dividends has been paid out around 10 times. As on 17 Jun, 2026, 03:56 PM IST, The overall dividend yield for Bajaj Healthcare stands at 0.5%. The last dividend paid was on September 19, 2025 (Rs. 1.0). The Earnings Per Share (EPS) for quarter ending 31st Mar 2026 is Rs. 4.68.

Bajaj Healthcare Bonus: The most recent bonus issue had been in year April 9, 2019 around 7 years ago at 1 : 1 ratio. The first bonus issue was announced in Feb 2019.

Stock Forecast:
After showing 156.01 Cr. of sales and 4.21% of quarterly net loss, there have been multiple ups and downs in the Bajaj Healthcare stock prices in the past few weeks. For example, Bajaj Healthcare stock price on 9th of June 2026 was around Rs. 292.1. Bajaj Healthcare share price now stands at an average of Rs. 299.20. Judging by last week's performance, stock is in up trend.

Bajaj Healthcare has a median target price of Rs. 0.0 in 12 months by 0 analysts. They have provided a high estimate of Rs. 0.0 and low estimate of Rs. 0.0 for Bajaj Healthcare share.

Historical Prices and Performance:
Bajaj Healthcare, incorporated in 1993 is a Small Cap company (with a market cap of Rs. 1017.62) operating in Pharmaceuticals sector.
The Return of Equity (ROE) in last five financial years given by Bajaj Healthcare stock was 2.95%, 8.47%, -30.1%, 11.7% and 21.73% respectively.
The Bajaj Healthcare share gave a 3 year return of -5.38% as compared to Nifty 50 which gave a return of 27.43%.
Bajaj Healthcare announced 20.0% final dividend on September 19, 2025.

Key Metrics:
PE Ratio of Bajaj Healthcare is 64.54
Prices/Sales Ratio of Bajaj Healthcare is 1.6
Price/Book Ratio of Bajaj Healthcare is 1.91

Peer Insights:
Peers are businesses with comparable activities, buisness objectives and affiliation with a particular industry area. For Bajaj Healthcare, major competitors and peers include Ind-Swift Labs, Jagsonpal Pharm, Syncom Form and Lincoln Pharma. As of Dec 2025, the dividend yield of Bajaj Healthcare stands at 0.5% while Ind-Swift Labs, Jagsonpal Pharm, Syncom Form and Lincoln Pharma stand at 0.0%, 1.91%, 0.0% and 0.0% respectively. The PE ratio and PB Ratio of the company are among its competitors stand at 64.54 and 1.91 respectively.

Leadership of Bajaj Healthcare :
Monica Tanwar is Co. Secretary & Compl. Officer
Rohan Parekh is Chief Financial Officer
Sajankumar R Bajaj is Chairman & Managing Director
Anil C Jain is Managing Director
Pakshal A Jain is Whole Time Director
Namrata S Bajaj is Whole Time Director
Kejal N Shah is Independent Director
Ram B Banarase is Independent Director
Hemant R Karnik is Independent Director
Yaqoob Ali is Independent Director

Show More

Industry

Pharma - Indian

Key Indices Listed On

BSE Healthcare

Address

602-606, Bhoomi Velocity Infotech Park,Plot No. B-39, B-39/A, B-39 A/1,Road No. 23,Thane, Maharashtra - 400604

Contact

investors@bajajhealth.com

http://www.bajajhealth.com

Executive Leadership

SR

Sajankumar R Bajaj

Chairman & Managing Director

AC

Anil C Jain

Managing Director

NS

Namrata S Bajaj

Whole Time Director

PA

Pakshal A Jain

Whole Time Director

Show More

Auditors

Walker Chandiok & Co. LLP

Chaturvedi & Agrawal

Paresh Rakesh & Associates

FAQs about Bajaj Healthcare share

1. What's the Bajaj Healthcare share price today?
Bajaj Healthcare share price is Rs 299.20 as on 17 Jun, 2026, 03:56 PM IST. Bajaj Healthcare share price is down by 1.03% based on previous share price of Rs 299.2. Bajaj Healthcare share price trend:
- Last 12 Months: Bajaj Healthcare share price moved down 43.85%
- Last 3 Years: Bajaj Healthcare Share price moved down by 6.35%
2. What has been highest price of Bajaj Healthcare share in last 52 weeks?
In last 52 weeks Bajaj Healthcare share had a high price of Rs 552.60 and low price of Rs 272.35
3. What's the market capitalization of Bajaj Healthcare?
Within the Pharmaceuticals sector, Bajaj Healthcare stock has a market cap rank of 88. Bajaj Healthcare has a market cap of Rs 1,007.19 Cr.
4. What is the PE & PB ratio of Bajaj Healthcare?
The PE ratio of Bajaj Healthcare stands at 64.54, while the PB ratio is 1.91.
5. What are the returns for Bajaj Healthcare share?
Return Performance of Bajaj Healthcare Shares:
- 1 Week: Bajaj Healthcare share price moved up by 2.76%

Top Gainers

As on 03:59 PM | 17 Jun 2026

90.36

13.21 (17.13%)

1,266.60

85.20 (7.22%)

28.20

1.88 (7.11%)

3,102.80

205.00 (7.08%)

Olectra Greentech

1,354.90

84.50 (6.66%)

Top Losers

As on 03:59 PM | 17 Jun 2026

360.95

-32.66 (-8.30%)

3,999.20

-163.20 (-3.93%)

479.20

-17.50 (-3.53%)

876.15

-31.50 (-3.48%)

967.60

-30.20 (-3.03%)

Equity Quick Links

Top Gainers
Top Losers
Hourly gainers
Hourly losers
Sensex
Nifty
NSE
BSE

Midcap stocks
Smallcap stocks
Largecap stocks
Sensex
Nifty
NSE
BSE
MCX Live

More from Markets

IPO
Stock market news
Budget 2022 Live Updates
Cryptocurrency
Currency converter
NSE holiday list

Trending in Markets

DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this site, you agree to the Terms of Service and Privacy Policy.